A hybrid drug delivery system coloaded with different drugs for synergistic drug delivery was developed. Alginate/calcium carbonate (CaCO3) hybrid microparticles (MPs) were fabricated via a facile coprecipitation method under mild conditions without using any organic solvent and surfactant. Due to the incorporation of negatively charged alginate chains onto the surface, the obtained hybrid MPs with spherical morphology showed good colloidal stability in an aqueous solution. An antitumor drug (doxorubicin, DOX) and a drug resistance reversal agent (verapamil, VP) were coloaded in the hybrid MPs simultaneously to obtain dual-drug-loaded MPs (DOX/VP/MP). Due to the presence of inorganic CaCO3 (∼54 wt%), the drugs could be loaded in the hybrid MPs with high encapsulation efficiency and the drug release could be effectively sustained. The cell growth inhibition of the drug-loaded MPs was evaluated in HeLa cells. An in vitro study showed DOX/VP/MP exhibited higher cell growth inhibition as compared with DOX monodrug-loaded MPs (DOX/MP). These results suggest the hybrid MPs can potentially be used as a synergistic drug delivery platform for cancer chemotherapy.

Keywords:
Drug delivery, Cancer therapy, Microparticles
1.
Farokhzad OC, Langer R: Impact of nanotechnology on drug delivery. ACS Nano 2009;3:16-20.
2.
Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC: Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 2013;66:2-25.
3.
Liang P, Zhao D, Wang CQ, Zong JY, Zhuo RX, Cheng SX: Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug delivery. Colloids Surf B Biointerfaces 2013;102:783-788.
4.
Rosler A, Vandermeulen GWM, Klok HA: Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev 2011;53:95-108.
5.
Wei H, Zhang XZ, Zhou Y, Cheng SX, Zhuo RX: Self-assembled thermoresponsive micelles of poly(N-isopropylacrylamide-b-methylmethacrylate). Biomaterials 2006;27:2028-2034.
6.
Wei H, Cheng SX, Zhang XZ, Zhuo RX: Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers. Prog Polym Sci 2009;34:893-910.
7.
Chacko RT, Ventura J, Zhuang J, Thayumanavan S: Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv Drug Deliv Rev 2012;64:836-851.
8.
Oishi M, Nagasaki Y: Stimuli-responsive smart nanogels for cancer diagnostics and therapy. Nanomedicine 2010;5:451-468.
9.
Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC: Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angew Chem Int Ed Engl 2014;18:8975-8979.
10.
Such GK, Johnston AP, Caruso F: Engineered hydrogen-bonded polymer multilayers: from assembly to biomedical applications. Chem Soc Rev 2011;40:19-29.
11.
Becker AL, Johnston AP, Caruso F: Layer-by-layer-assembled capsules and films for therapeutic delivery. Small 2010;6:1836-1852.
12.
Luo GF, Xu XD, Zhang J, Yang J, Gong YH, Lei Q, Jia HZ, Li C, Zhuo RX, Zhang XZ: Encapsulation of an adamantane-doxorubicin prodrug in pH-responsive polysaccharide capsules for controlled release. ACS Appl Mater Interfaces 2012;4:5317-5324.
13.
Ueno Y, Futagawa H, Takagi Y, Ueno A, Mizushima Y: Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release 2005;103:93-98.
14.
Wei W, Ma GH, Hu G, Yu D, Mcleish T, Su ZG, Shen ZY: Preparation of hierarchical hollow CaCO3 particles and the application as anticancer drug carrier. J Am Chem Soc 2008;130:15808-15810.
15.
Zhao D, Zhuo RX, Cheng SX: Alginate modified nanostructured calcium carbonate with enhanced delivery efficiency for gene and drug delivery. Mol Biosyst 2012;8:753-759.
16.
Wang C, Liu H, Gao Q, Liu X, Tong Z: Alginate-calcium carbonate porous microparticle hybrid hydrogels with versatile drug loading capabilities and variable mechanical strengths. Carbohydr Polym 2008;71:476-480.
17.
Shi J, Zhang Z, Li G, Cao S: Biomimetic fabrication of alginate/CaCO3 hybrid beads for dual-responsive drug delivery under compressed CO2. J Mater Chem 2011;21:16028-16034.
18.
Perkin KK, Turner JL, Wooley KL, Mann S: Fabrication of hybrid nanocapsules by calcium phosphate mineralization of shell cross-linked polymer micelles and nanocages. Nano Lett 2005;5:1457-1461.
19.
Zhao Q, Han QB, Wang Z, Gao C, Peng C, Shen J: Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies. Nanomedicine 2007;3:63-74.
20.
Wang J, Chen JS, Zong JY, Zhao D, Li F, Zhuo RX, Cheng SX: Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery. J Phys Chem C 2010;114:18940-18945.
21.
Dai GH, Tong YL, Chen X, Ren ZM, Yang F: In vitro anticancer activity of myricanone in human lung adenocarcinoma A549 cells. Chemotherapy 2014;60:81-87.
22.
Eckel F, Schmid RM: Chemotherapy and targeted therapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Chemotherapy 2014;60:13-23.
23.
Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
24.
Fardel O, Lecureur V, Guillouzo A: The P-glycoprotein multidrug transporter. Gen Pharmacol 1996;27:1283-1291.
25.
Stavrovskaya AA: Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry 2000;65:95-106.
26.
Lombardi G, Pambuku A, Bellu L, Della Puppa A, Rumano L, Gardiman MP, Pomerri F, Zagonel V: Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma. Chemotherapy 2013;59:176-180.
27.
Ramos JR, Roma E, Palomar L, Poveda JL: Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy. Chemotherapy 2013;59:344-345.
28.
Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
29.
Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981;41:1967-1972.
30.
Cullen KV, Davey RA, Davey MW: Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells. Biochem Pharmacol 2001;62:417-424.
31.
Pouget EM, Bomans PHH, Dey A, Frederik PM, de With G, Sommerdijk NAJM: The development of morphology and structure in hexagonal vaterite. J Am Chem Soc 2010;132:11560-11565.
32.
Olton D, Li J, Wilson ME, Rogers T, Close J, Huang L, Kumta PN, Sfeir C: Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: influence of the synthesis parameters on transfection efficiency. Biomaterials 2007;28:1267-1279.
33.
Long X, Ma YR, Qi LM: In vitro synthesis of high Mg calcite under ambient conditions and its implication for biomineralization process. Cryst Growth Des 2011;11:2866-2873.
34.
Yu CY, Jia LH, Yin BC, Zhang XZ, Cheng SX, Zhuo RX: Fabrication of nanospheres and vesicles as drug carriers by self-assembly of alginate. J Phys Chem C 2008;112:16774-16778.
35.
Wang J, Chen B, Zhao D, Peng Y, Zhuo RX, Cheng SX: Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency. Int J Pharm 2013;446:205-210.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.